BlackRock Fund Advisors’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $4.81M | Sell |
574,555
-249,871
| -30% | -$2.09M | ﹤0.01% | 2956 |
|
|
2016
Q3 | $5.66M | Buy |
824,426
+48,815
| +6% | +$335K | ﹤0.01% | 2790 |
|
|
2016
Q2 | $3.84M | Buy |
775,611
+71,882
| +10% | +$356K | ﹤0.01% | 2954 |
|
|
2016
Q1 | $6.8M | Buy |
703,729
+10,320
| +1% | +$99.7K | ﹤0.01% | 2575 |
|
|
2015
Q4 | $6.5M | Buy |
693,409
+300,956
| +77% | +$2.82M | ﹤0.01% | 2689 |
|
|
2015
Q3 | $5.52M | Buy |
392,453
+47,117
| +14% | +$662K | ﹤0.01% | 2747 |
|
|
2015
Q2 | $7.26M | Buy |
345,336
+183,236
| +113% | +$3.85M | ﹤0.01% | 2691 |
|
|
2015
Q1 | $6.81M | Buy |
162,100
+4,361
| +3% | +$183K | ﹤0.01% | 2664 |
|
|
2014
Q4 | $3.71M | Buy |
157,739
+16,177
| +11% | +$380K | ﹤0.01% | 3017 |
|
|
2014
Q3 | $2.12M | Buy |
+141,562
| New | +$2.12M | ﹤0.01% | 3114 |
|